FBL is a pioneering developer of immobilized enzyme catalysts which has transformed the way the antibiotics are manufactured. Our enzyme technologies enable new and eco-friendly manufacturing practices to sectors ranging from the pharmaceutical industry, fine chemicals to bioplastics, cosmetics, to mention the few.
Inspirted by nature, biotech division develops novel enzymes and "smart" enzyme technologies, which are evolved in myriad ways to provide unique process and product advantages. Some of the flagship enzyme products range from the classical "white enzyme", Penicillin G amidase-(PA 850) to the more advanced enzyme variants like Novel Penicillin G Amidase (PS 250) and CALB Lipase (CALB10000)
FBL is a leader in providing immobilized enzymes and enzyme technologies, and proprietary immobilization platforms. Our enzyme technologies for the synthesis of beta lactams and cephalosporin antibiotics offer unique advantages, which are not only scalable but also enable competitive transformation.
We also offer enzyme immobilization optimization and supply services of various scale upto multi-ton commercial quantities.